Division of Basic Medical Research Practical Research Project for Allergic Diseases and Immunology

1. This project supports research and development on allergic and/or immunological diseases shown in the figure below. For efficient utilization of the research and development funds, this project does not support research that mainly targets "designated intractable diseases".

2. This project supports the following research and development aimed at maintaining and improving the QOL of patients.

• Research on pathogenesis of diseases: High-quality basic research on the etiology and pathogenesis of diseases, creation of disease models, and discovery of drug seeds, etc.
• Research on improvement of medical practice quality: Research aimed at improving the quality of medical practice through the creation of high-quality evidences.
• Research and development of pharmaceutical products (Step 0/1/2). Step 0 (Discovery phase) : Research promoting the development of novel drugs, Step 1 (Pre-clinical phase) : Research and development of GMP grade manufacturing or GLP studies preparing for clinical trials, Step 2 (Clinical phase) : Investigator -initiated clinical trials (Phase I, Phase II, Obtaining POC, etc.)

Figure : Allergic and immunological diseases supported in this project.

PS (Program Supervisor)

• IIZUKA Hajime, M.D., Ph.D., Director, Kojinkai, Association of Medical Corporation, Research Institute of Psoriasis

PO (Program Officer)

• ADACHI Yuichi, M.D., Ph.D., Director, Toyama Red Cross Hospital Pediatric Allergy Center
• KUWANA Masataka, M.D., Ph.D., Chief Professor, Nippon Medical School Graduate School of Medicine
• TAKENAKA Hiroshi, M.D., Ph.D., Representative Director, The Systemic Research Group about Medicine & Health Care
• TADA Yayoi, M.D., Ph.D., Chief Professor, Teikyo University School of Medicine
• TAMARI Mayumi, M.D., Ph.D., Professor, The Jikei University School of Medicine